Trulieve Cannabis Corp. (TRLV) Financials

TRLV Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 2.1 billion 1.3 billion
March 31, 2026 2.8 billion 1.6 billion
Dec. 31, 2025 2.7 billion 1.6 billion
Sept. 30, 2025 2.9 billion 1.8 billion

TRLV Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 32.1 million 6.9 million
March 31, 2026 42.2 million 4.1 million
Dec. 31, 2025 52.2 million 4.0 million
Sept. 30, 2025 60.3 million 5.8 million

TRLV Net Income

No data available :(

TRLV Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 325.4 million 235.0 million 287.9 million
March 31, 2026 352.9 million 285.7 million 338.8 million
Dec. 31, 2025 255.5 million 227.6 million 332.0 million
Sept. 30, 2025 449.2 million 473.8 million 335.5 million

TRLV Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 192.3 million
March 31, 2026 192.3 million
Dec. 31, 2025 192.3 million
Sept. 30, 2025 191.1 million

TRLV Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 21.0 million - 101.8 million -
March 31, 2026 13.5 million - 104.9 million -
Dec. 31, 2025 7.0 million - 126.3 million -
Sept. 30, 2025 16.5 million - 99.0 million -

TRLV Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 271.0 million 108.7 million
March 31, 2026 286.8 million 116.7 million
Dec. 31, 2025 293.1 million 118.0 million
Sept. 30, 2025 288.2 million 118.3 million

TRLV

Price: $9.47

52 week price:
4.62
13.28

Earnings Per Share: -2.39 USD

Exchange: NYQ

Sector: Healthcare

Industry: Pharmaceuticals

Market Capitalization: 1.8 billion

Links: